Sintx Technologies (SINT) Cash from Financing Activities (2013 - 2026)
Sintx Technologies (SINT) posted Cash from Financing Activities of $247000.0 for Q1 2026, down 10.51% on a QoQ basis from $276000.0 in Q4 2025, and down 94.21% year-over-year from $4.3 million in Q1 2025.
Powered by 
Analysis
Sintx Technologies (SINT) Cash from Financing Activities (2013 - 2026) Analysis & Trends
Sintx Technologies has reported Cash from Financing Activities for 14 years, with the latest figure at $247000.0 in Q1 2026.
- On a quarterly basis, Cash from Financing Activities fell 94.21% year-over-year to $247000.0 in Q1 2026; TTM through Mar 2026 was $4.2 million, a 47.95% decrease from a year earlier, with the FY2025 full-year figure at $8.2 million, down 9.83% from the prior year.
- Cash from Financing Activities was $247000.0 for Q1 2026 at Sintx Technologies, down from $276000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $11.5 million in Q1 2023, with the low at -$123000.0 in Q2 2025.
- Average Cash from Financing Activities over 5 years is $2.5 million, with a median of $1.0 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities soared 96025.0% in 2022, then tumbled 132.8% in 2024.
- Over 5 years, Cash from Financing Activities stood at $3.8 million in 2022, then plunged by 91.91% to $311000.0 in 2023, then sank by 132.8% to -$102000.0 in 2024, then soared by 370.59% to $276000.0 in 2025, then declined by 10.51% to $247000.0 in 2026.
- The last three Cash from Financing Activities figures came in at $247000.0 (Q1 2026), $276000.0 (Q4 2025), and $3.8 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Sintx Technologies | 7.90 Mn | 7.90 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 247,000.00 |
| Dec 31, 2025 | 276,000.00 |
| Sep 30, 2025 | 3.78 Mn |
| Jun 30, 2025 | -123,000.00 |
| Mar 31, 2025 | 4.27 Mn |
| Dec 31, 2024 | -102,000.00 |
| Sep 30, 2024 | 2.86 Mn |
| Jun 30, 2024 | 1.01 Mn |
| Mar 31, 2024 | 5.33 Mn |
| Dec 31, 2023 | 311,000.00 |
| Sep 30, 2023 | -88,000.00 |
| Mar 31, 2023 | 11.49 Mn |
| Dec 31, 2022 | 3.85 Mn |
| Dec 31, 2021 | 4,000.00 |
| Jun 30, 2021 | -5,000.00 |
| Mar 31, 2021 | 706,000.00 |
| Dec 31, 2020 | -16,000.00 |
| Sep 30, 2020 | 10.53 Mn |
| Jun 30, 2020 | 10.97 Mn |
| Mar 31, 2020 | 9.44 Mn |